Effect of pravastatin on outcomes after cardiac transplantation. - Wikidata - wikimedia - TriplyDB

Effect of pravastatin on outcomes after cardiac transplantation.

Effect of pravastatin on outcomes after cardiac transplantation.

http://www.wikidata.org/entity/Q46203599

about

Atorvastatin added to interferon beta for relapsing multiple sclerosis: 12-month treatment extension of the randomized multicenter SWABIMS trial Pleiotropic effects of statins Current status of paediatric heart, lung, and heart-lung transplantation The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins Are statins anti-inflammatory?What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?New immunosuppressive drugs in heart transplantation HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotection Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases?Put your heart into the joint benefits of statins!Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis.Pediatric Statin Administration: Navigating a Frontier with Limited Data Detection of transplant vasculopathy in a rat aortic allograft model by fluorescence spectroscopic optical analysis Opportunities for the treatment of inflammation in cardiovascular disease Ongoing clinical trials of the pleiotropic effects of statins Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease Tacrolimus/cerivastatin interaction study in liver transplant recipients Statin treatment in multiple sclerosis: a systematic review and meta-analysis.The effects of atorvastatin in experimental autoimmune uveitis SWiss Atorvastatin and interferon Beta-1b trial In Multiple Sclerosis (SWABIMS)--rationale, design and methodology.Statin treatment and mortality in bacterial infections--a systematic review and meta-analysis Heart transplantation: approaching a new century.Surgical biology for the clinician: vascular effects of immunosuppression Persistence with statins and onset of rheumatoid arthritis: a population-based cohort study.Is there an anti-inflammatory effect of statins in rheumatoid arthritis? Analysis of a large routinely collected claims database Donor-Transmitted Atherosclerosis Associated With Worsening Cardiac Allograft Vasculopathy After Heart Transplantation: Serial Volumetric Intravascular Ultrasound Analysis Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation.Fluvastatin in combination with cyclosporin in renal transplant recipients: a review of clinical and safety experience.Recent Advances in the Prevention of Coronary Artery Diseases: Focus on Primary Prevention.Cardiac allograft vasculopathy: current knowledge and future direction.The effect of simvastatin on lowering panel reactive antibody titer in sensitized dialysis patients: a randomized placebo controlled clinical trial.Coronary microvasculopathy in heart transplantation: Consequences and therapeutic implications.Effect of simvastatin, an established lipid-lowering drug, on pulmonary Chlamydia pneumoniae infection in mice.Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation.Pediatric heart transplantation-indications and outcomes in the current era.Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials.Weight gain and cardiovascular risk after organ transplantation.Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.

P2860

Q21559486-A662B703-A183-47CD-95B3-10E351B23C9E Q24647863-F5ABDD81-A12B-46DB-A306-61943D540165 Q24675133-47ACF7CD-82D9-4BF3-9D9A-8B8F8D26BE92 Q24684244-B7BE5015-4C85-40E8-A7B1-56682509D9C9 Q24792912-6C6BD284-9113-4A48-A839-EAFD58D8B841 Q24792926-261EC7CC-AD13-417A-9537-A69878A721EA Q24793542-DE28382F-0EBC-47BF-BBC7-1FE6E7CB7823 Q24793685-42CEC491-6AAC-40E4-BF4D-B0DE773F8DE6 Q24794301-F5853280-0EFD-48FE-9B25-4C438E0D26C0 Q24804153-10F49DF5-8F1D-4847-9810-DAEE2C82B862 Q24805105-2006AA0B-624C-43AC-824D-DB2314C0A7EC Q27011330-B1EB4628-EBD1-40E9-8B9F-C25AE49EA450 Q28068014-C07F18AB-F5B3-4132-AE4C-BA76C2A37907 Q28139659-4788B119-7237-4F1D-BEB0-C6FC53F29654 Q28192292-07C86AAA-46F3-4F00-95A1-1F2B74089982 Q28219321-9C576FF0-2441-4E31-8536-98BF477D798A Q28219483-7C07321A-46F1-4F51-AF06-7D841E3DA0A6 Q28345569-A833733E-B9D0-42E9-AE96-8E235DBC5D82 Q30913423-DB2660E2-C80A-465E-B991-9A8ECE215AFA Q33212135-872A5817-BC1C-415F-9FA6-CC2449C678C6 Q33571416-0865CDC5-E70E-4D77-8B20-8B4C1860775B Q33587600-7CAA6023-CA83-470F-84E6-0132620694DF Q33601849-578B9415-260B-4ABB-9BB4-A2FC908A6CA8 Q33604754-1CA89405-DBDE-422D-8BBB-B1D763593896 Q33691624-11B61CC2-9D4D-4823-B65C-91F3E37E5D8C Q33696612-FB6338E8-2D53-41D1-B9FC-2EFB48A53074 Q33719657-BF25EDB5-7AAC-4DCB-B8FE-1928EA326D6D Q33769533-3D28E08D-E845-455D-9A2E-0C9B257AE9EC Q33826469-BFD7205D-436B-4B32-96C8-D354B341452F Q33843402-8DC31E54-6BD3-4C16-8A0C-533CDE0B8FBD Q33860323-A6792180-3653-4566-9908-E55FFADF6BE5 Q33871644-9CA11E82-A229-4705-B0FB-E59B44438EF0 Q33891755-E538BA06-6B47-44FC-B443-4C32FA8028E8 Q33935447-16F5D783-2409-4382-9AA4-6DA668A4C981 Q33960556-5046D2C5-FF7F-44F4-805D-005E74FEDE70 Q34012822-469E3B7D-071A-4E8D-B7A3-72F0635A417B Q34048053-44CB54F4-BF64-4383-9B5F-E1401FAA21D1 Q34142678-4471AF1F-8B02-4426-BC90-573C25B35352 Q34239244-B763A878-163B-4BD9-BEE9-A5203EC94015 Q34362144-67B60618-5411-4B87-829A-B1F6986B065E

P2860

Effect of pravastatin on outcomes after cardiac transplantation.

http://www.wikidata.org/entity/Q46203599

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年学术文章

@wuu

1995年学术文章

@zh-cn

1995年学术文章

@zh-hans

1995年学术文章

@zh-my

1995年学术文章

@zh-sg

1995年學術文章

@yue

1995年學術文章

@zh

1995年學術文章

@zh-hant

name

Effect of pravastatin on outcomes after cardiac transplantation.

@en

Effect of pravastatin on outcomes after cardiac transplantation.

@nl

type

label

Effect of pravastatin on outcomes after cardiac transplantation.

@en

Effect of pravastatin on outcomes after cardiac transplantation.

@nl

prefLabel

Effect of pravastatin on outcomes after cardiac transplantation.

@en

Effect of pravastatin on outcomes after cardiac transplantation.

@nl

P1433

Q46203599-4883518C-D126-4F74-B148-FB12FAA1CF4D

P1476

Q46203599-3176F4E7-F053-4B98-A4E5-51DC3BCE00AD

P2093

Q46203599-228E720C-75E8-48F8-A03C-95085D05C9E2

Q46203599-3BAB825A-C10C-4BCE-A1B2-69221E433547

Q46203599-5AF3F764-D07C-4ACD-84B8-74ECC66C780B

Q46203599-6A56D621-1869-4443-A62D-818B899A067A

Q46203599-6B421A75-CF55-42B7-AF9A-AF7D23C5223E

Q46203599-7FBDA311-5618-43A6-B6D5-B15B7A4335A5

Q46203599-9E4A2BBB-6E59-4B0B-B1AB-E9A544D529A6

Q46203599-D065375D-69A0-450B-9DF0-39A690170B25

Q46203599-FC943C3E-F880-4C4B-BA6A-9CB62BEA8451

P304

Q46203599-A4D86341-6B93-4CA3-9534-6A1576248953

P31

Q46203599-EE458F81-02C9-455F-BDB7-81A4968AD910

P356

Q46203599-8D310AB0-BC68-4BD6-B981-B2784E2E5512

P407

Q46203599-4D337EC0-DF85-4EDB-A4B4-53E30E215B88

P433

Q46203599-8B8368B0-EDBC-4949-8C9F-A41D9AE80FA0

P478

Q46203599-11C2A8AD-2AC1-46EC-813C-377B0847892D

P50

Q46203599-6C5BC036-242D-4832-8C49-5BC92FB5D808

P577

Q46203599-D45BC097-EA9C-4171-B016-8F146FAAB7DE

P5875

Q46203599-995EA7AF-35B7-446E-B66B-A0799FCDB897

P698

Q46203599-6DC18C0C-F7B4-4801-A1AE-A5E9291F3B65

P356

NEJM199509073331003

P1433

The New England Journal of Medicine

P1476

Effect of pravastatin on outcomes after cardiac transplantation

@en

P2093

Chia D

http://www.w3.org/2001/XMLSchema#string

Cogert GA

http://www.w3.org/2001/XMLSchema#string

Johnson JA

http://www.w3.org/2001/XMLSchema#string

Katznelson S

http://www.w3.org/2001/XMLSchema#string

Laks H

http://www.w3.org/2001/XMLSchema#string

Sabad A

http://www.w3.org/2001/XMLSchema#string

Terasaki PI

http://www.w3.org/2001/XMLSchema#string

Wang XM

http://www.w3.org/2001/XMLSchema#string

Yeatman L

http://www.w3.org/2001/XMLSchema#string

P304

621-627

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJM199509073331003

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

333

http://www.w3.org/2001/XMLSchema#string

P50

Jon A Kobashigawa

P577

1995-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15560871

http://www.w3.org/2001/XMLSchema#string

P698

7637722

http://www.w3.org/2001/XMLSchema#string